Transcat, Inc. (NASDAQ:TRNS) Given Consensus Recommendation of “Moderate Buy” by Analysts

Transcat, Inc. (NASDAQ:TRNS) has received an average rating of “Moderate Buy” from the five brokerages that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has issued a hold rating, two have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $105.3333.

TRNS has been the subject of several research reports. Weiss Ratings upgraded shares of Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research note on Thursday, May 28th. Wall Street Zen downgraded shares of Transcat from a “hold” rating to a “sell” rating in a research note on Saturday, June 20th. Finally, Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a research note on Friday, May 15th.

Transcat Trading Up 0.2%

NASDAQ:TRNS opened at $89.63 on Friday. Transcat has a 12 month low of $50.23 and a 12 month high of $94.76. The firm has a fifty day simple moving average of $81.80 and a 200-day simple moving average of $73.03. The company has a current ratio of 2.33, a quick ratio of 1.99 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $837.14 million, a P/E ratio of 154.54 and a beta of 0.71.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings data on Tuesday, May 26th. The scientific and technical instruments company reported $0.56 EPS for the quarter, topping the consensus estimate of $0.51 by $0.05. Transcat had a net margin of 1.62% and a return on equity of 5.84%. The business had revenue of $89.33 million during the quarter, compared to the consensus estimate of $89.79 million. On average, equities research analysts anticipate that Transcat will post 1.71 earnings per share for the current year.

Institutional Investors Weigh In On Transcat

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Lazard Asset Management LLC acquired a new position in Transcat during the second quarter valued at $54,000. Tower Research Capital LLC TRC lifted its position in Transcat by 245.5% during the second quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company’s stock valued at $97,000 after purchasing an additional 798 shares during the period. PNC Financial Services Group Inc. lifted its position in Transcat by 42.7% during the third quarter. PNC Financial Services Group Inc. now owns 1,530 shares of the scientific and technical instruments company’s stock valued at $112,000 after purchasing an additional 458 shares during the period. Marshall Wace LLP acquired a new position in Transcat during the fourth quarter valued at $236,000. Finally, Balyasny Asset Management L.P. acquired a new position in Transcat during the fourth quarter valued at $247,000. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.